Viewing data from:

TRILAFON

NDA

PERPHENAZINE | N011294 | SCHERING CORP SUB SCHERING PLOUGH CORP

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain5 active DMFs3 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

TRIFARMA SPAPERPHENAZINE USP

DMF 41301981

APICORE PHARMACEUTICALS PRIVATE LTDPERPHENAZINE USP

DMF 246462012

EMCURE PHARMACEUTICALS LTDPERPHENAZINE USP

DMF 272242013

MACLEODS PHARMACEUTICALS LTDPERPHENAZINE

DMF 307562016

JUBILANT BIOSYS LTDPERPHENAZINE USP

DMF 313792017

ORION CORP LTDInactivePERPHENAZINE

DMF 32731978

ORCHIMIE SA (PRODUITS CHIMIQUES ET BIOCHIMIQUES)InactivePERPHENAZINE

DMF 66451986

FINE CHEMICALS CORPInactivePERPHENAZINE

DMF 85561990

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#002 — 2MG/5ML

0 patents0 exclusivities▴

SYRUP;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.